Costa Rica vs Syria: Lung cancer death rates
Costa Rica
3.24 deaths per 100,000 people
in 2022
Syria
3.25 deaths per 100,000 people
in 2010
Costa Rica rank
93rd
Syria rank
92nd
Lung cancer death rates over time
- Costa Rica
- Syria
How they compare
Syria currently reports 3.25 deaths per 100,000 people against 3.24 deaths per 100,000 people in Costa Rica, a difference of 0.01 deaths per 100,000 people.
Across all 13 years both countries report, Costa Rica has been ahead every year.
Costa Rica ranks 93rd and Syria ranks 92nd of 111 countries.
Costa Rica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Syria | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 4.87 deaths per 100,000 people | 2.3 deaths per 100,000 people | 2.57 deaths per 100,000 people | Costa Rica |
| 2000s | 4.37 deaths per 100,000 people | 2.94 deaths per 100,000 people | 1.44 deaths per 100,000 people | Costa Rica |
| 2010s | 4.14 deaths per 100,000 people | 3.25 deaths per 100,000 people | 0.8981 deaths per 100,000 people | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher lung cancer death rates, Costa Rica or Syria?
- Syria, at 3.25 deaths per 100,000 people against 3.24 deaths per 100,000 people in Costa Rica as of 2010.
- What is the difference in lung cancer death rates between Costa Rica and Syria?
- 0.01 deaths per 100,000 people, with Syria ahead.
- How many years of comparable data are there for Costa Rica and Syria?
- 13 years are reported by both, from 1998 to 2010.
- How do Costa Rica and Syria rank globally for lung cancer death rates?
- Costa Rica ranks 93rd and Syria ranks 92nd of 111 countries.
- Where does this data come from?
- WHO Mortality Database (2025) – with minor processing by Our World in Data, published as Lung cancer death rates. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported deaths from trachea, bronchus, lung cancers in females in those aged all ages per 100,000 people.